More about
Mgmt-Hypermethylated Glioblastoma
News
November 01, 2024
2 min read
Save
Addition of veliparib to temozolomide fails to extend survival in glioblastoma
The addition of veliparib to adjuvant temozolomide failed to improve OS for patients with newly diagnosed, MGMT-hypermethylated glioblastoma, according to randomized phase 2/phase3 study results.